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1. Introduction 
Peptide elongation on mammalian ribosomes 
requires two different enzymes present in the soluble 
fractions of the cell. Transferase I binds the amino- 
acyl-tRNA to the acceptor site [l] while the trans- 
location of peptidyl-tRNA from the donor to the 
acceptor site is catalyzed by transferase II [2]. 
Transfer factors from different mammalian species 
are apparently interchangeable [3]. Even bacterial T 
factor can replace transferase I in mammalian systems 
[4] . Similarly, algal transfer factors are active with 
ribosomes from E. coli [5]. On the other hand, 
E. coli G factor cannot replace mammalian TF II [4] . 
A similar result was found with yeast transfer enzymes 
tested with E. coli ribosomes [6]. These results seem 
to indicate that peptide elongation reactions are 
limited by species- or perhaps even organ-specificity. 
Moreover, no systematic experiments were reported 
as yet on the specificity of the other tissue components 
used in peptide elongation experiments, i.e. ribosomes 
and tRNA. 
This paper reports results obtained with different 
combinations of tissue preparations from rat liver and 
human tonsils that indicate a considerable species- 
specificity of some of these components. 
2. Materials and methods 
Peptide elongation factors from rat liver and human 
tonsils were prepared by the method of Bermek and 
Matthaei [7,8] . Ribosomes from both tissues were 
purified as described by the same authors [9]. 
Methods used for the assay of polyudirected poly- 
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phenylalanine synthesis were described elsewhere 
[ 10, 1 I] . All incubation mixtures contained saturating 
quantities of tRNA and both elongation enzymes while 
the amount of ribosomes was kept limiting. 
3. Results and discussion 
A summary of results obtained with 3 different 
batches of elongation factors and ribosomes and with 
2 preparations of tRNA from both sources are given 
in tables 1 and 2. 
Apparently a rather low species-specificity is 
exhibited by tRNA in peptide elongation reactions. 
This explains why even bacterial tRNA may be succsess- 
fully used with mammalian ribosomes and transfer 
factors [3,7-91. Addition of heterologous ribosomes 
Table 1 
Polyphenylalanine synthesis in combined systems containing 
14C-tRNA from rat liver. 
Transferase I Transferase II 
Ribosomes 
- 
Rat Human 
rat 
rat 
human 
human 
rat 
human 
rat 
human 
29.0 8.7 
48.0 48.9 
10.4 4.2 
32.5 34.0 
~-~ 
Incubation mixtures contained 0.8 mg of ribosomes/ml, 
saturating amounts of tRNA and both elongation factors as 
well as all other components of the standard polymerization 
assay [ lo] . All values are pmoles of ’ 4C-Phe polymerized/ml 
of reaction mixture (30 min, 37’). 
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Table 2 
Polyphenylalanine synthesis in combined systems containing 
14C-Phe-tRNA from human tonsils. 
Transferase I Transferase II 
Ribosomes 
- 
Rat Human 
rat rat 22.2 6.6 
rat human 44.6 38.0 
human rat 5.5 7.8 
human human 41.3 41.0 
Incubation mixtures contained 0.8 mg of ribosomal/ml, 
saturating amounts of tRNA and both elongation factors as 
well as all other components of the standard polymerization 
assay [lo]. All values are pmoles of ’ 4C-Phe polymerized/ml 
of reaction mixture (30 min, 37’). 
to rat liver systems significantly inhibits peptide 
elongation. However, no such effect is seen with 
human tonsil systems. Also transferase I shows a high 
species-specificity in rat liver systems but not in in- 
cubation mixtures containing components of human 
tonsils. Surprisingly, the phenylalanine polymerization 
in all combinations tested is limited by the origin of 
transferase II. In general, systems containing human 
tonsil transferase II show a much higher polyphenyl- 
alanine synthesis than corresponding mixtures with 
rat liver translocase (fig. 1). The phenylalanine 
polymerization in homologous rat liver systems 
!io lo3 l?io 
M mdw~ 
Fig. 1. Effect of increasing amounts of rat liver (-) or 
human tonsil (@--o ) peptidyl-tRNA translocase on the polyU- 
directed polyphenylalanine synthesis in a homologous rat 
liver system. 
containing human tonsil TF II is even more intensive 
than in homologous human tonsil mixtures. More- 
over, mixtures containing human tonsil translocase are 
much less sensitive to the addition of the other heter- 
ologous components than systems with rat liver TF II. 
It is scarcely possible to explain at the moment 
this rather strange activity of human tonsil transferase 
II. Since saturating amounts of transfer enzymes were 
used in our experiments the possibility of a higher 
specific activity of human translocase when compared 
with the corresponding enzyme of rat liver can be 
excluded. Besides that, comparable results in this 
respect were obtained with different batches of both 
elongation factors and ribosomes. The higher activity 
of human tonsil translocase is apparently a property 
of this enzyme itself since it is not limited by the 
origin of ribosomes. Thus it would seem that the 
mechanism of transferase II action in different species 
may be different. This could explain the specificity of 
reticulocyte translocase which, unlike transferase I, 
cannot be replaced by the corresponding bacterial 
enzyme [4] . 
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